Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.41B | 1.40B | 1.39B | 1.39B | 8.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.41B | 1.40B | 1.39B | 1.39B | 8.00M |
| Cost of Revenue | 62.40K | 62.40K | 120.70K | -854.80K | 452.00K |
| Gross Profit | 1.41B | 1.40B | 1.39B | 1.39B | 7.55M |
| SG&A Expenses | 76.98M | 75.40M | 83.10M | 67.02M | 61.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 26.60M | 29.70M | 29.70M | 29.70M | 3.10M |
| Total Operating Expenses | 379.01M | 349.42M | 310.85M | 282.50M | 211.98M |
| Operating Income | 1.03B | 1.05B | 1.08B | 1.10B | -203.98M |
| Income Before Tax | 1.05B | 1.07B | 1.09B | 1.11B | -170.96M |
| Income Tax Expenses | 83.34M | 83.20M | 87.39M | 81.31M | -615.60K |
| Earnings from Continuing Operations | 969.15 | 982.39 | 999.89 | 1.02K | -170.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 969.15M | 982.39M | 999.89M | 1.02B | -170.35M |
| EBIT | 1.03B | 1.05B | 1.08B | 1.10B | -203.98M |
| EBITDA | 1.03B | 1.06B | 1.08B | 1.11B | -201.01M |
| EPS Basic | 13.69 | 13.88 | 14.13 | 14.48 | -2.49 |
| Normalized Basic EPS | 9.22 | 9.29 | 9.54 | 9.70 | -1.64 |
| EPS Diluted | 13.47 | 13.66 | 13.91 | 14.25 | -2.49 |
| Normalized Diluted EPS | 9.07 | 9.14 | 9.39 | 9.55 | -1.64 |
| Average Basic Shares Outstanding | 281.99M | 282.06M | 282.44M | 282.81M | 274.76M |
| Average Diluted Shares Outstanding | 282.98M | 283.04M | 283.43M | 283.79M | 274.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |